AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 15 filers reported holding AERPIO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $322,000 | +126.8% | 257,554 | 0.0% | 0.01% | +100.0% |
| Q1 2020 | $142,000 | -11.8% | 257,554 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $161,000 | -8.0% | 257,554 | 0.0% | 0.01% | -25.0% |
| Q3 2019 | $175,000 | -74.0% | 257,554 | -65.2% | 0.01% | -70.4% |
| Q2 2019 | $673,000 | +0.9% | 740,000 | 0.0% | 0.03% | 0.0% |
| Q1 2019 | $667,000 | -48.7% | 740,000 | -3.3% | 0.03% | -51.8% |
| Q4 2018 | $1,301,000 | -45.0% | 765,000 | 0.0% | 0.06% | -34.9% |
| Q3 2018 | $2,364,000 | -25.5% | 765,000 | 0.0% | 0.09% | -28.3% |
| Q2 2018 | $3,175,000 | – | 765,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 450,676 | $1,870,000 | 2.33% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,103,554 | $4,580,000 | 0.63% |
| Granite Point Capital Management, L.P. | 750,000 | $3,113,000 | 0.28% |
| Orbimed Advisors | 5,193,946 | $21,555,000 | 0.26% |
| NEXTHERA CAPITAL LP | 298,873 | $1,240,000 | 0.19% |
| Artal Group S.A. | 1,558,400 | $6,467,000 | 0.14% |
| Tekla Capital Management LLC | 765,000 | $3,175,000 | 0.12% |
| NEVILLE RODIE & SHAW INC | 100,000 | $415,000 | 0.04% |
| Ascent Wealth Partners, LLC | 10,000 | $41,000 | 0.01% |
| MOORE CAPITAL MANAGEMENT, LP | 100,000 | $415,000 | 0.01% |